This is an Instagram account from University of Washington Health promoting COVID-19 vaccines for pregnant women.
Source: @One Vax Two Lives Covid-19 Vaccine Promotion for Pregnant Women
Views 27
This series of cross-sectional studies explores the effect of the COVID-19 pandemic on demand- and supply-side factors affecting maternal, newborn, and child health (MNCH) service utilization in Kenya, Malawi and Mozambique. The studies reveal the extent to which the COVID-19 pandemic impacted people’s willingness and ability to access essential MNCH services, their experiences of care, and the health system’s readiness to continue to provide essential care during the pandemic.
Source: Continuity of essential health services in Kenya, Malawi and Mozambique
Views 422
Although the population of Côte d’Ivoire has reached 58% of the vaccination target, there is still work to be done to encourage people with doubts to get vaccinated. The government of Côte d’Ivoire has authorized the Pfizer vaccine for pregnant women since January 2023 (Circular 00103/2023). Breakthrough ACTION supports the government of Côte d’Ivoire through social and behavior change (SBC) interventions, including research and monitoring to inform COVID-19 vaccination activities. The Breakthrough ACTION team, in partnership with the Department of Health and USAID, collected qualitative data from three sites to assess concern about COVID-19, perceptions of the current vaccine rollout, standards perceptions around vaccination, how misinformation and other factors influence vaccine uptake. This analysis focuses on a subset of data relating to perceptions of COVID-19 among pregnant women.
Views 117
A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding).
Source: Study confirms link between COVID-19 vaccination and temporary increase in menstrual cycle length
Views 127
In this systematic review and meta-analysis, COVID-19 vaccination during pregnancy was not associated with increased risks of peripartum adverse outcomes, including preterm birth, small size for gestational age, low Apgar score at 5 minutes, cesarean delivery, postpartum hemorrhage, and chorioamnionitis.
Source: Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy
Views 111
These are resources and tools from the CDC to help pregnant and recently pregnant people, breastfeeding people and new parents caring for infants protect their health and help people who serve these communities communicate with them during the COVID-19 pandemic.
Source: Toolkit for Pregnant people and new parents
Views 159
With the COVID-19 pandemic entering its fourth year, we asked UNICEF health experts to explain what we now know about the best ways for pregnant women to protect themselves and their babies.
Views 206
The ‘Follow Who Know Road’ television spots are one-minute videos explaining why vaccination against COVID-19 is essential.
Sources:
Views 210
South Africa’s National Department of Health has published new guidelines for the care of mothers and newborns in the context of the ever-present threat of COVID-19. The guidelines incorporate new scientific and operational evidence. The aim is to ensure that clinical care for mothers, babies and children during the pandemic remains relevant, practical and evidence-based.
Source: How South Africa is integrating COVID
Views 221
This leaflet was developed by Ghana Health Service and Breakthrough ACTION, with key messages about COVID-19 vaccination for pregnant women. It contains Frequently Asked Questions(FAQs) with basic answers to serve as a reference for health workers, and other community members, especially pregnant women to increase knowledge of COVID-19 vaccination for pregnant women.
Source: Facts About COVID-19 Vaccination for Pregnant Women
Views 492
This website is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the Breakthrough ACTION Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at Johns Hopkins Center for Communication Programs (CCP).The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or Johns Hopkins University.
